Hepatoprotective effect of Omega-3 PUFAs against acute paracetamol- induced hepatic injury confirmed by FTIR
| dc.Affiliation | October University for modern sciences and Arts (MSA) | |
| dc.contributor.author | El-Gendy, Zeinab A | |
| dc.contributor.author | El-Batran, Seham A | |
| dc.contributor.author | Youssef, SAH | |
| dc.contributor.author | Ramadan, A | |
| dc.contributor.author | El Hotaby, Walid | |
| dc.contributor.author | Bakeer, Rofanda M | |
| dc.date.accessioned | 2020-09-29T08:06:43Z | |
| dc.date.available | 2020-09-29T08:06:43Z | |
| dc.date.issued | 2021-03-01 | |
| dc.description | SJR 2024 0.726 Q2 H-Index 95 | |
| dc.description.abstract | Acute paracetamol over dose-induced hepatotoxicity is considered an important medical hazard especially among women. Omega-3 long-chain polyunsaturated fatty acids (Omega-3 PUFAs) daily doses are nowadays recommended for their antioxidant and anti-inflammatory potentials. Fourier transform infrared (FTIR) spectroscopy is considered a reliable method in analyzing cellular alterations and is now efficiently used to diagnose several diseases and the efficacy of drugs even in the early stages. The aim of our study was to evaluate the hepatoprotective effect of Omega-3 PUFAs against paracetamol-induced hepatotoxicity in rats confirmed through measuring protein alterations in hepatocytes by FTIR. Rats were pretreated with Omega-3 PUFAs (50 and 100 mg/kg) for 21 days prior to oral ingestion of paracetamol. FTIR results revealed that Omega-3 PUFAs (50 mg/kg) limited the toxic effects of paracetamol by restoring the hepatic amide I to amide II ratio. In addition; biochemical analyses demonstrated that serum ALT, AST, Cholesterol, LDL-cholesterol and Il-6 levels as well as hepatic TNF-α, MDA, NOx levels were decreased. Besides; serum HDL-cholesterol level and hepatic GSH level were increased. Histopathological examinations of hepatic sections validated the hepatoprotective potential. The overall effect of this dose was comparable to those of the usual recommended hepatoprotective supplement; silymarin. In conclusion; it would be recommended to use Omega-3 PUFAs in low doses on daily bases as a hepatoprotective agent. | en_US |
| dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=25106&tip=sid&clean=0 | |
| dc.identifier.citation | El-Gendy, Z. A., El-Batran, S. A., Youssef, S., Ramadan, A., Walid El Hotaby, Bakeer, R. M., & Ahmed, R. F. (2020). Hepatoprotective effect of Omega-3 PUFAs against acute paracetamol-induced hepatic injury confirmed by FTIR. Human & Experimental Toxicology, 40(3), 526–537. https://doi.org/10.1177/0960327120954522 | |
| dc.identifier.doi | https://doi.org/10.1177/0960327120954522 | |
| dc.identifier.other | https://doi.org/10.1177/0960327120954522 | |
| dc.identifier.uri | https://t.ly/D0pj | |
| dc.language.iso | en_US | en_US |
| dc.publisher | SAGE Publications Inc. | en_US |
| dc.relation.ispartofseries | Human and Experimental Toxicology;Volume 40, Issue 3, March 2021, Pages 526-537 | |
| dc.subject | FTIR | en_US |
| dc.subject | liver injury | en_US |
| dc.subject | Omega-3 | en_US |
| dc.subject | paracetamol | en_US |
| dc.title | Hepatoprotective effect of Omega-3 PUFAs against acute paracetamol- induced hepatic injury confirmed by FTIR | en_US |
| dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- el-gendy-et-al-2020-hepatoprotective-effect-of-omega-3-pufas-against-acute-paracetamol-induced-hepatic-injury-confirmed.pdf
- Size:
- 832.84 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 51 B
- Format:
- Item-specific license agreed upon to submission
- Description:
